IXICO plc

13.00pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:IXIHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 10Y CAGR (6.03%)
Div yield —
ROE (15.80%)
Biotechnology
Beta (5Y) (0.01)
PE TTM —
TSR TTM 15.56%
Mkt cap £28.47M
ROIC (29.85%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
16p
24.60%
29.59%
Hold 11|11|7|0|10
1Q26
2Q26
3Q26
4Q26
Earnings per share£
0.31
0.32
0.34
0.33
10.06%
1.50%
15.03%
2.67%
Revenue£M
2.475
2.461
2.550
2.516
3.33%
3.18%
1.74%
3.34%
Peers (US$39.28M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
3.823
1.997
1.839
EBIT/Intx
1.355
0.512
0.431
Own earn%
42.42
(7.58)
(9.47)
Sh yield%
36.59
15.12
16.27
Owners
Insiders/Inst%
5.23
64.22
Short interest%
2.61
SBC / revenue%
2.77
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
19–25
$1 testx
1.0
Incr. ROIC%
4